Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28400196)

  • 1. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
    Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion.
    Biener-Ramanujan E; Rosier F; Coetzee SG; McGovern DDP; Hazelett D; Targan SR; Gonsky R
    Front Immunol; 2022; 13():999155. PubMed ID: 36466822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.
    Gonsky R; Deem RL; Landers CJ; Haritunians T; Yang S; Targan SR
    Inflamm Bowel Dis; 2014 Oct; 20(10):1794-801. PubMed ID: 25171510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
    Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
    J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.
    Richard AC; Peters JE; Savinykh N; Lee JC; Hawley ET; Meylan F; Siegel RM; Lyons PA; Smith KGC
    PLoS Genet; 2018 Sep; 14(9):e1007458. PubMed ID: 30199539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.
    Michelsen KS; Thomas LS; Taylor KD; Yu QT; Mei L; Landers CJ; Derkowski C; McGovern DP; Rotter JI; Targan SR
    PLoS One; 2009; 4(3):e4719. PubMed ID: 19262684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
    Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
    Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.
    Lan X; Lan X; Chang Y; Zhang X; Liu J; Vikash V; Wang W; Huang M; Wang X; Zhou F; Chen L; Zhao Q
    Cell Physiol Biochem; 2017; 41(5):2077-2090. PubMed ID: 28456797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.
    Barrett R; Zhang X; Koon HW; Vu M; Chang JY; Yeager N; Nguyen MA; Michelsen KS; Berel D; Pothoulakis C; Targan SR; Shih DQ
    Am J Pathol; 2012 Feb; 180(2):636-49. PubMed ID: 22138299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TNF family member TL1A induces IL-22 secretion in committed human T
    Thomas LS; Targan SR; Tsuda M; Yu QT; Salumbides BC; Haritunians T; Mengesha E; McGovern DP; Michelsen KS
    J Leukoc Biol; 2017 Mar; 101(3):727-737. PubMed ID: 27733581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.
    Gonsky R; Deem RL; Landers CJ; Derkowski CA; Berel D; McGovern DP; Targan SR
    Inflamm Bowel Dis; 2011 Jan; 17(1):171-8. PubMed ID: 20848535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-543-3p promotes locomotor function recovery after spinal cord injury by inhibiting the expression of tumor necrosis factor superfamily member 15 in rats.
    Li XZ; Lv CL; Shi JG; Zhang CX
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2701-2709. PubMed ID: 31002119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.
    Shih DQ; Barrett R; Zhang X; Yeager N; Koon HW; Phaosawasdi P; Song Y; Ko B; Wong MH; Michelsen KS; Martins G; Pothoulakis C; Targan SR
    PLoS One; 2011 Jan; 6(1):e16090. PubMed ID: 21264313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.